We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$17B
AUM Growth
+$1.79B
Cap. Flow
-$229M
Cap. Flow %
-1.35%
Top 10 Hldgs %
33.75%
Holding
1,490
New
144
Increased
706
Reduced
317
Closed
73

Top Buys

Rank Stock Value
1
O icon
Realty Income
O
+$448M
2
AMT icon
American Tower
AMT
+$132M
3
HIW icon
Highwoods Properties
HIW
+$92.2M
4
WELL icon
Welltower
WELL
+$79.2M
5
PLD icon
Prologis
PLD
+$71.1M

Sector Composition

Rank Sector Weight
1 Real Estate 60.4%
2 Technology 9.49%
3 Consumer Discretionary 4.17%
4 Communication Services 4.01%
5 Financials 3.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UA icon
1076
Under Armour Class C
UA
$2.89B
$29K ﹤0.01%
1,632
GEN icon
1077
PUT
Gen Digital
GEN
$16.7B
$28K ﹤0.01%
5,000
+2,896
+138% +$73.3K
UTHR icon
1078
United Therapeutics
UTHR
$25.9B
$28K ﹤0.01%
131
-23
-15% -$4.51K
RSX
1079
DELISTED
VanEck Russia ETF
RSX
$27K ﹤0.01%
1,000
BFAM icon
1080
Bright Horizons
BFAM
$4.32B
$26K ﹤0.01%
205
-350
-63% -$48.6K
NTLA icon
1081
Intellia Therapeutics
NTLA
$1.47B
$26K ﹤0.01%
217
-35
-14% -$4.38K
EWW icon
1082
iShares MSCI Mexico ETF
EWW
$1.88B
$25K ﹤0.01%
500
UDMY
1083
DELISTED
Udemy
UDMY
$25K ﹤0.01%
+1,300
New +$31.1K
MRTX
1084
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$24K ﹤0.01%
161
-16
-9% -$2.48K
MEDP icon
1085
Medpace
MEDP
$16.1B
$23K ﹤0.01%
105
-18
-15% -$3.77K
NWS icon
1086
News Corp Class B
NWS
$17.6B
$21K ﹤0.01%
954
ARWR icon
1087
Arrowhead Research
ARWR
$12.1B
$20K ﹤0.01%
305
-52
-15% -$3.57K
CNQ icon
1088
Canadian Natural Resources
CNQ
$96.5B
$19K ﹤0.01%
919
CVAC
1089
DELISTED
CureVac
CVAC
$19K ﹤0.01%
+545
New +$21.9K
OGE icon
1090
OGE Energy
OGE
$10B
$19K ﹤0.01%
500
OUT icon
1091
Outfront Media
OUT
$5.76B
$19K ﹤0.01%
728
-19
-3% -$489
PEI
1092
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$19K ﹤0.01%
1,255
+108
+9% +$2.32K
BPMC
1093
DELISTED
Blueprint Medicines
BPMC
$18K ﹤0.01%
172
-29
-14% -$3.03K
BNS icon
1094
Scotiabank
BNS
$106B
$17K ﹤0.01%
235
+45
+24% +$2.97K
EXEL icon
1095
Exelixis
EXEL
$14B
$17K ﹤0.01%
923
-156
-14% -$2.98K
HALO icon
1096
Halozyme
HALO
$9.9B
$17K ﹤0.01%
411
-76
-16% -$2.84K
RARE icon
1097
Ultragenyx Pharmaceutical
RARE
$2.5B
$17K ﹤0.01%
199
-33
-14% -$2.69K
ARNA
1098
DELISTED
Arena Pharmaceuticals Inc
ARNA
$17K ﹤0.01%
179
-30
-14% -$1.98K
BEAM icon
1099
Beam Therapeutics
BEAM
$2.66B
$16K ﹤0.01%
199
-28
-12% -$2.4K
DNLI icon
1100
Denali Therapeutics
DNLI
$3.78B
$16K ﹤0.01%
356
-61
-15% -$2.89K

Similar funds

Daiwa Securities Group's Q4 2021 Portfolio in Review

As of Q4 2021, Daiwa Securities Group held 1,490 positions worth $17B, up 12% from $15.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group's Q4 2021 filing shows 144 new, 706 increased, 317 reduced and 73 closed positions. Its largest new stake was State Street SPDR Portfolio S&P 500 High Dividend ETF: 333,500 shares worth $14M. The largest sale was VEREIT, Inc., an estimated $434M.

By sector, the portfolio is most concentrated in Real Estate at 60% of assets, up from 56% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q4 2021 buy was State Street SPDR Portfolio S&P 500 High Dividend ETF: 333,500 shares worth $14M.
  • Daiwa Securities Group added most to Realty Income in Q4 2021, an estimated $448M increase.
  • Daiwa Securities Group's biggest Q4 2021 reduction was CyrusOne Inc Common Stock, cutting an estimated $386M.
  • Daiwa Securities Group fully exited VEREIT, Inc. in Q4 2021, selling an estimated $434M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $17B portfolio in Q4 2021.
  • Daiwa Securities Group opened 144 new positions and closed 73 in Q4 2021.
  • Daiwa Securities Group's portfolio value rose 12% quarter-over-quarter to $17B.

Based on Daiwa Securities Group's 13F filing for Q4 2021, filed 3 Feb 2022.